SCOPUS 정보 검색 플랫폼

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 10, 2011, Pages 2127-2129

Low-molecular-weight-heparin and pregnancy, when the dose does it: A nephrologist's opinion: A rebuttal

(7) Stratta, P a Canavese, C a Cena, T b Quaglia, M a Pergolini, P c Bellomo, G c Magnani, C b

a Nephrology and Transplantation (France)

b MAGGIORE DELLA CARITÀ HOSPITAL (Italy)

c UNIVERSITY OF EASTERN PIEDMONT (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BODY MASS; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; GLOMERULUS FILTRATION RATE; HIGH RISK PREGNANCY; HUMAN; KIDNEY CLEARANCE; LETTER; LIVE BIRTH; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 80053402237 PISSN: 15387933 EISSN: 15387836 Source Type: Journal
DOI: 10.1111/j.1538-7836.2011.04436.x Document Type: Letter

Times cited : (2)

References (8)

1
- 79952078261
- Prophylaxis with low-dose low-molecular-weight-heparin during pregnancy and postpartum: is it effective?
- Roeters van Lennep JE, Meijer E, Klumper FJ, Middeldorp JM, Bloemenkamp KW, Middeldorp S. Prophylaxis with low-dose low-molecular-weight-heparin during pregnancy and postpartum: is it effective? J Thromb Haemost 2011; 9: 473-80.
- (2011) J Thromb Haemost , vol.9 , pp. 473-480
- Roeters van Lennep, J.E.¹ Meijer, E.² Klumper, F.J.³ Middeldorp, J.M.⁴ Bloemenkamp, K.W.⁵ Middeldorp, S.⁶

2
- 77952981639
- Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis
- Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010; 115: 1256-62.
- (2010) Obstet Gynecol , vol.115 , pp. 1256-1262
- Ziakas, P.D.¹ Pavlou, M.² Voulgarelis, M.³

3
- 0037870646
- A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy
- Sephton V, Farquharson RG, Topping J, Quenby SM, Cowan C, Back DJ, Toh CH. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003; 101: 1307-11.
- (2003) Obstet Gynecol , vol.101 , pp. 1307-1311
- Sephton, V.¹ Farquharson, R.G.² Topping, J.³ Quenby, S.M.⁴ Cowan, C.⁵ Back, D.J.⁶ Toh, C.H.⁷

4
- 4444279681
- Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
- Ensom MH, Stephenson MD. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig 2004; 11: 377-83.
- (2004) J Soc Gynecol Investig , vol.11 , pp. 377-383
- Ensom, M.H.¹ Stephenson, M.D.²

5
- 55449127268
- Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
- Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstet Gynecol 2008; 112: 884-9.
- (2008) Obstet Gynecol , vol.112 , pp. 884-889
- Fox, N.S.¹ Laughon, S.K.² Bender, S.D.³ Saltzman, D.H.⁴ Rebarber, A.⁵

6
- 77950519729
- Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy
- Friedrich E, Hameed AB. Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy. J Perinatol 2010; 30: 253-7.
- (2010) J Perinatol , vol.30 , pp. 253-257
- Friedrich, E.¹ Hameed, A.B.²

7
- 70349404307
- Structure-activity relationships of low molecular weight heparins expose to the risk of achieving inappropriate targets in patients with renal failure
- Stratta P, Karvela E, Canavese C, Quaglia M, Lazzarich E, Fenoglio R, Pergolini P, Bellomo G, Cena T, Magnani C. Structure-activity relationships of low molecular weight heparins expose to the risk of achieving inappropriate targets in patients with renal failure. Curr Med Chem 2009; 16: 3028-40.
- (2009) Curr Med Chem , vol.16 , pp. 3028-3040
- Stratta, P.¹ Karvela, E.² Canavese, C.³ Quaglia, M.⁴ Lazzarich, E.⁵ Fenoglio, R.⁶ Pergolini, P.⁷ Bellomo, G.⁸ Cena, T.⁹ Magnani, C.¹⁰

8
- 77949918374
- Using low molecular weight heparin in special patient populations
- Lim W. Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 2010; 29: 233-40.
- (2010) J Thromb Thrombolysis , vol.29 , pp. 233-240
- Lim, W.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.